We're going to start with getting all those complete response letters. We're going to find exactly what issues the FDA listed for their nose. In one of those cases, the complete response letter admitted they didn't look at like four or five of the submissions of information the companies had provided. They just said no. So I can't explain it. I'm going to learn a whole lot more about it over the next couple months. (20:07–20:15)
CLAIM
Claims the FDA admitted in a response letter that they did not review several submissions from companies.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.